CMP Phar.ma, a company that specializes in the production of inspection systems for the pharmaceutical industry, opened a 5,000 sqare meter plant in Vicenza Italy. 

The Marchesini Group, a Bologna-based multinational producer of machines for packaging pharmaceutical and cosmetic industry products, is enabling CMP Phar.ma to contribute its inspection machines, including those used for packaging Covid vaccines and cancer drugs, types of biologic drugs that require an extremely high level of quality control.

“The new plant will become the heart of the production operation, while the warehouse and the company’s R&D department will remain at the current site nearby,” said Luigi Pilastro CEO of CMP Phar.ma. “At both sites we will work to conceive and produce new inspection machine models to complete the range, to enable us to break into important markets such as North America and China. At the same time, we’ll push ahead with development of our program based on artificial intelligence.”

The aim of the project, which will start to produce the first demos as early as 2024, is to introduce AI as standard on all inspection machines.

“At CMP Phar.ma and within Marchesini Group, we make use of AI algorithms both for the predictive maintenance of our machines and to improve the vision and inspection systems used during packaging cycles, as well as to increase the intelligence of the robotics needed to handle products on our lines,” said Maurizio Marchesini chairman of Marchesini Group. “The already impressive results are helping to improve production quality and to release human beings from repetitive tasks and free them up for more ‘human’ jobs.”